SSR2 and meningioma: On the contrary, the data from the aforementioned study provide a valuable insight into the still not fully understood role of SSR2 in meningioma biology, also supporting PRRT for grade 1 and 2 lesions and for transosseus localizations, which may be particularly challenging both for surgical and RT approaches.